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A B S T R A C T
The study presents results in treatment of pathologic fractures of long bones of all patients who underwent surgery in
the last 10 years in our hospital. The study cohort comprised 133 consecutive patients divided in two groups who under-
went surgery of long bone fractures caused by metastatic tumor or trauma. We used resection, open reduction and plating
with bone cement application for pathologic fracture and some cases of femoral shaft fractures were stabilized with
intramedullary nailing. Proximal femoral fractures were treated with hip arthroplasty or dynamic hip screw. There were
2 amputations performed: one case of pathologic fracture of tibia and one case of humeral fracture. The present study
compares results between two group of patients. We noted: age, gender, fracture site, choice of the surgical procedure, hos-
pital stay, need for analgesia after surgery, postoperative complications, and reached level of physical activity after sur-
gery. The mean survival rate was 8.1 months. Seventeen patients experienced postoperative complications. We also found
statistically significant improvement in functional scores (MSTS and TESS) in surgically treated patients with patho-
logic fractures. There are many different techniques of surgical treatment of pathologic fractures caused by skeletal
metastases including arthroplasty or a combination of internal fixation combined with polymethyl methacrylate
(PMMA) that provides immediate fixation and stability. The present study showed that surgical treatment of pathologic
fractures caused by skeletal metastases in vast majority of cases provides bone healing after pathologic fracture, with
signifficant improvement of physical activity and rehabilitation in the investigated group.
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Introduction
Prolonged life expectancy and increased incidence of
different site tumors are a noticeable feature of the de-
veloped countries1. Malignant diseases are the second
most common disease category regarding incidence and
mortality2.
The bone presents one of the most common sites of
metastatic occurance3. Skeletal metastases cause serious
clinical problems in patients with cancer, usually severe
pain and functional disability4. Secondary tumors inter-
fere with metabolism and biomechanics of the bone caus-
ing pathologic fractures5,6 (Figure 1 and 2). The majority
of studies advocate surgery as an effective palliation me-
thod in bone metastases. It spears the patients of cast
and probably improves quality of life. The successful sur-
gical treatment of pathologic fractures caused by meta-
static tumors is considered if there is a significant pain
level decrease as well as satisfactory restoration of the
functional status7.
The present study analyze results in surgical treatment
of pathologic fractures and reached level of physical activ-
ity of patients with skeletal metastases in comparison with
patients with trauma sustained fractures of a long bones.
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Patients and Methods
The study cohort comprised 133 consecutive patients
who underwent surgery of long bone fractures caused by
metastatic tumor or trauma. There were two group of pa-
tients: tumor group included 67 patients (male n=23, fe-
male n=44) and non-tumor group included 66 patients
(male n=23, female n=43), with an average age 73 years.
The patients in tumor group underwent surgery of pa-
thologic fractures of following long bones: femur (58
cases), humerus (8 cases) and tibia (1 case). The non-tu-
mor, control group consisted of patients with femoral (58
cases) and humeral fractures (8 cases).
All patients were treated at the Department of Ortho-
paedic and Trauma Surgery, University Hospital »Sestre
milosrdnice«, Zagreb, Croatia in the ten year period.
Both groups of patients underwent a bone scan preopera-
tively to evaluate bone density of the remaining skeleton,
and to avoid pathological fractures caused by occult skel-
etal metastasis. The following surgical procedures were
employed in both groups: plating n=90, intramedullary
nailing n=14, hip hemiarthropalsty n=15, dynamic hip
screw n=8, total hip arthroplasty n=4, amputation n=2
(Table 2). In all cases we used the combination of inter-
nal fixation or arthroplasty and bone cement. After open-
ing the fracture site, we performed curettage of the met-
astatic tumor, filled the bone defect and medullar canal
with bone cement and finally reduction and standard
plating. In some cases of shaft pathologic fracture we em-
ployed intramedullary nailing with open approach, tu-
mor resection and reduction with gap filling with bone
cement. We employed hip replacement if there is signifi-
cant bone loss caused by osteolytic effect of the meta-
static tumor progression. All procedures were performed
by three staff orthopaedic surgeons. After surgical treat-
ment patients received postoperative radiotherapy to
prevent possible local recurrence of the tumor.
We noted: age, gender, fracture site, choice of the sur-
gical procedure, postoperative complications, hospital
stay, need for analgesia after surgery and reached level of
physical activity after surgery. The final function and ac-
tivity of tumor group was evaluated according to the
Musculoskeletal Tumor Society (MSTS) score and the
Toronto Extremity Salvage Score (TESS). All patients,
both with pathologic and traumatic fractures, were in-
vited for follow-up examinations, along with radiographs
of affected limb on 1st postoperative day, than 6 weeks, 3
months, and 1year after surgery or until patient’s death.
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Fig. 1. Pathological fractures of humerus. Pre-operative and
post-operative.
Fig. 2. Pathological fractures of femur (pre-operative).
TABLE 1
PRIMARY TUMOR DISTRIBUTIONS IN TUMOR GROUP OF PA-
TIENTS









SURGICAL PROCEDURES EMPLOYED IN BOTH GROUPS
Procedure Tumor group (n) Non-tumor (n) Total




Hip hemiarthroplasty 7 8 15
Dynamic hip screw 4 4 8
Total hip arthroplasty 2 2 4
Amputation 2 0 2
Total 67 66 133
The data were tested for significance using the two-tailed
unpaired Student’s t-test and beta coefficients less then
0.05 was considered statistically significant.
Results
The mean hospital stay was similar between the two
groups of patients: 8.2±2.0 days for tumor group and
7.4±1.5 for non-tumor group (p=0.07), and as such, was
considered to be not statistically significant. Local and
systemic complications after surgery appeared in 17 pa-
tients: 12 tumor and 5 non-tumor patients.
Six patients in tumor group required reoperation: 3
cases of fixation failure, 2 cases of aseptic loosening of
the hip endoprosthesis and 1 case of deep wound infec-
tion. The average survival rate was 7.8 months. We found
statistically significant difference in duration of analge-
sic therapy between two group of patients, p=0.03 (tu-
mor group 6.5±1.1 days and non-tumor group 5.9±1.0).
We noted statistically significant progression in func-
tional recovery of surgically treated patients with patho-
logical fractures. The MSTS increased from 11.9±1.8 at 6
weeks to 16.2±1.1 at 3 months postoperatively (p=0.0001).
We also found statistically significant increase in TESS
from 49.7±19.2 at six weeks to 60.7±20.1 three months
after surgery (p=0.0001).
Discussion
Management of skeletal metastases remains a topi-
cal issue due to poor long term results despite the num-
ber of different treatment protocols proposed by numer-
ous authors.
There are some major disadvantages in surgical treat-
ment of pathologic fractures caused with metastatic dis-
ease including overall deterioration and synchronous
metastatic lesions. Bone metastases are the result of
hematogenous dissemination of tumor cells and surgical
treatment of pathologic fractures of limb bones is exclu-
sively palliative. The goals of the surgical treatment are
well known and include: relieving pain, assessing histo-
logical diagnosis, fracture fixation and restoration of the
function with intention of an early ambulation and qual-
ity of life improvement. Demographic data presented in
this study showed a higher number of female patients in
both investigated groups.
The vast majority of authors report similar findings8,9.
The following factors may contribute to this demogra-
phic distribution: bone metastases are the most fre-
quently caused by breast cancer, incidence vary between
30% and 50%9. Patients with primary breast carcinoma
have higher survival rate but increased risk for bone
metastases occurrence10,11. The majority of cases had
pathologic femoral fracture (n=58) and only 8 patients
sustained humeral fracture, this incidence of the site of
the pathologic fracture is supported by other authors3,8.
The numerous authors consider that intramedullary nai-
ling should be method of choice for femoral and humeral
shaft fractures, as well as arthroplasty for proximal fem-
oral fractures12–15. In the present study the choice of sur-
gical procedure mainly depended on the fracture site,
number of metastases, a tumor local progression and
general health condition of the patients. Seventeen pa-
tients experienced postoperative complications during
postoperative period. We found 5 cases in tumor-group
with local postoperative complications requiring reope-
ration because of loosening and dislocation of the hip re-
placement or loss of fixation at the fracture site. All of 2
cases of hip arthroplasty dislocation as well as 2 cases of
DHS and 1 case of femoral shaft fracture managed with
plating combined with resection and bone cement were
caused by local recurrence of a tumor, regardless postop-
erative chemo and radiotherapy. One patient in tumor
group had transitory radial nerve palsy after fixation of
the humeral shaft fracture which was fully recovered.
There was also one case of deep wound infection in each
group required revision surgery. One patient from each
group died in the early postoperative period. The other
systemic complications were moderate in nature and suc-
cessfully treated conservatively with cooperation with
different specialists. The other authors notify similar
complication rates8,16–18. We found significant improve-
ment in recovery and physical activity using MSTS and
TESS scoring system in surgically treated patients with
pathologic fractures. These findings are comparable to
those reported by authors and confirm results found in
the literature19–21. Patients in tumor group received anal-
getics longer period of time in comparison with patients
in other group. The possible causes that could contribute
to prolonged perioperative pain in patients with patho-
logic fractures might be addition of pain caused by pri-
mary tumor or multiple skeletal metastases. Talbot and
many other authors support this observation as well as
favorably results in relieving pain in surgically treated
patients18,19,22. A proper surgical procedure resulted in
satisfactory local tumor control and vast majority of pa-
tients in tumor group (96.4%) achieved ambulation within
few weeks after surgery.
We found tumor recurrence rate among patient co-
hort to be acceptable (7.5%) and comparable to those re-
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TABLE 3








Dislocation of arthroplasty 2 0 2
Fixation failure 3 1 4
Nerve palsy 1 0 1
Wound infection 1 1 2
Pneumonia 1 2 3
Deep vein thrombosis 2 0 2
Stroke 1 0 1
Death 1 1 2
Total 12 5 17
ported by other authors23. In conclusion, in spite of short
life expectancy we believe that surgery is an effective tool
for restoration of limb function and improvement of pa-
tients life quality with pathologic fractures caused by
skeletal metastases.
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KIRUR[KO LIJE^ENJE PATOLO[KIH FRAKTURA U PACIJENATA SA METASTATSKIM
TUMORIMA
S A @ E T A K
Zahvaljaju}i napretku u lije~enju malignih bolesti a prema tome i produljenom o~ekivanom pre`ivljenju zamije}uje
se ve}a pojavnost ko{tanih metastaza. Ko{tane metastaze su posljedica hematogene diseminacije tumorskih stanica, a
kirur{ko lije~enje je jo{ uvijek isklju~ivo palijativnog karaktera. Ova studija je rezultat desetogodi{njeg pra}enja rezul-
tata lije~enje patolo{kih prijeloma dugih kostiju na na{oj Klinici. U studiji su komparirane dvije skupine pacijenata koji
su podvrgnuti kirur{kom lije~enju prijeloma dugih kostiju radi metastaza ili traume. Izbor operacijske metode je ovisio
o lokalizaciji, broju metastaza i lokalnoj tumorskoj progresiji. Kod lije~enja patolo{kog prijeloma u~injena je resekcija,
otvorena repozicija te osteosinteza plo~icom u kombinaciji sa ko{tanim cementom a odre|eni broj slu~ajeva prijeloma
dijafize bedrene kosti je zbrinut endomedularnom osteosintezom. Prijelomi proksimalnog okrajka bedrene kosti su
zbrinuti artroplastikom ili dinami~kim vijkom za kuk. Kod jednog slu~aja patolo{kog prijeloma tibije i humerusa u~i-
njena je amputacija. U studiji se uspore|uju rezultati dvije skupine pacijenata. Tumorsku skupinu ~ini 67 pacijenata sa
manifestnim patolo{kim prijelomom dugih kostiju a ne-tumorsku skupinu ~ini 66 pacijenata sa traumatskim prije-
lomom. U studiji se prate demografski ~imbenici (dob i spol), operacijska metoda, duljina hospitalizacije i analgezija,
poslijeoperacijske komplikacije te postignuta razina rehabilitacije i funkcije ekstremiteta. U sklopu pra}enja pacijenti
su podvrgnuti redovitim klini~kim kao i radiolo{kim kontrolama prvi poslijeoperacijski dan, {est tjedana kasnije, tri
mjeseca i godinu dana nakon operacije ili do smrti pacijenta. Za evaluaciju funkcionalnog statusa koristili smo: Mus-
culosceletal Tumor Society sustav verzija 1993 i Toronto Extremity Salvage Score. Za evaluaciju dobivenih rezultata
koristili smo se odgovaraju}om statisti~kom analizom (two-tailed unpaired Student’s t-test), a b koeficijent ve}i od 0,05
smo smatrali statisti~ki zna~ajnim.Prosje~na duljina hospitalizacije nije se bitno razlikaovala me|u ispitanicima u dvije
skupine. Prosje~na duljina pre`ivljenja je bila 8,1 mjesec. Sedamnaest pacijenata je imalo neku od poslijeoperacijskih
komplikacija. Na|en je tako|er statisti~ki zna~ajan napredak u funkcionalnom statusu kirur{ki lije~enih pacijenata sa
patolo{kim prijelomima. Patolo{ki prijelomi prouzro~eni ko{tanim metastazama predstavljaju jasnu indikaciju za ki-
rur{ko lije~enje jer kost pro`eta tumorskim tkivom gotovno nikada ne cijeli bez kirur{ke stabilizacije. Ciljevi stabi-
lizacije su smanjiti bol, pobolj{ati funkciju, pobolj{ati njegu pacijenta i kvalitetu preostalog `ivota. Postoji vi{e razli~itih
operacijskih metoda uklju~uju}i artoplastiku kao i kombinacije unutarnje fiksacije i ko{tanog cementa koji osigurava
trenuta~nu solidnu stabilnost. Nakon zavr{enog cijeljenja rane potrebno je provesti sukcesivno radioterapijsko lije~enje
koje }e omogu}iti cijeljenje te suzbijanje lokalnog recidiva. Ova studija dokazuje da u najve}em broju kirur{ki lije~enih
pacijenata dolazi do cijeljenja patolo{kog prijeloma kao i do zna~ajnog pobollj{anja funkcionalnog statusa.
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